Q4 FY2025 Earnings
Financial report interval: 2025.10.01 - 2025.12.31
Overview: NeuroSense Therapeutics - Unit(NRSN) the Revenue is 0 (--%), Meet estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
0.00B--
0.00B--%
EBIT
TBA--
-0.00B41.16%
----
EPS
TBA--
-0.0433.33%
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf